Research ArticleClinical Investigation
Impact of Posttreatment SPECT/CT on Patient Management During 177Lu-PSMA-617 Radiopharmaceutical Therapy
Surekha Yadav, Blair Lowery, Abuzar Moradi Tuchayi, Fei Jiang, Rachelle Saelee, Rahul R. Aggarwal, Roxanna Juarez, Robert R. Flavell and Thomas A. Hope
Journal of Nuclear Medicine September 2024, 65 (9) 1395-1401; DOI: https://doi.org/10.2967/jnumed.124.267955
Surekha Yadav
1Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, California;
Blair Lowery
1Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, California;
Abuzar Moradi Tuchayi
1Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, California;
Fei Jiang
2Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California;
Rachelle Saelee
1Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, California;
Rahul R. Aggarwal
3Division of Medical Oncology, Department of Medicine, University of California San Francisco, San Francisco, California;
Roxanna Juarez
1Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, California;
Robert R. Flavell
1Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, California;
4Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California; and
Thomas A. Hope
1Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, California;
4Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California; and
5Department of Radiology, San Francisco VA Medical Center, San Francisco, California

Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 65, Issue 9
September 1, 2024
Impact of Posttreatment SPECT/CT on Patient Management During 177Lu-PSMA-617 Radiopharmaceutical Therapy
Surekha Yadav, Blair Lowery, Abuzar Moradi Tuchayi, Fei Jiang, Rachelle Saelee, Rahul R. Aggarwal, Roxanna Juarez, Robert R. Flavell, Thomas A. Hope
Journal of Nuclear Medicine Sep 2024, 65 (9) 1395-1401; DOI: 10.2967/jnumed.124.267955
Impact of Posttreatment SPECT/CT on Patient Management During 177Lu-PSMA-617 Radiopharmaceutical Therapy
Surekha Yadav, Blair Lowery, Abuzar Moradi Tuchayi, Fei Jiang, Rachelle Saelee, Rahul R. Aggarwal, Roxanna Juarez, Robert R. Flavell, Thomas A. Hope
Journal of Nuclear Medicine Sep 2024, 65 (9) 1395-1401; DOI: 10.2967/jnumed.124.267955